Meeting to be held in Boston and New York on May 12-14 hosted by Maxim.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATHE:
- Alterity Therapeutics granted U.S. FDA Fast Track designation for ATH434
- Alterity Therapeutics Reports Positive Phase 2 Trial Results for MSA Treatment
- Alterity Therapeutics reports cash balance of A$17.96M as of March 31
- Alterity Therapeutics Announces Director Securities Changes
- Alterity presents ATH434-201 Phase 2 trial results at MSA Symposium